Bausch Health Cos Total Current Liabilities 2010-2024 | BHC

Bausch Health Cos total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Bausch Health Cos Annual Total Current Liabilities
(Millions of US $)
2023 $4,302
2022 $3,941
2021 $5,198
2020 $4,913
2019 $6,248
2018 $3,836
2017 $4,268
2016 $3,609
2015 $5,313
2014 $2,708
2013 $2,513
2012 $1,823
2011 $924
2010 $692
2009 $249
Bausch Health Cos Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $4,506
2024-06-30 $4,369
2024-03-31 $4,405
2023-12-31 $4,302
2023-09-30 $4,224
2023-06-30 $3,967
2023-03-31 $3,923
2022-12-31 $3,941
2022-09-30 $3,831
2022-06-30 $4,997
2022-03-31 $4,774
2021-12-31 $5,198
2021-09-30 $5,437
2021-06-30 $5,517
2021-03-31 $4,898
2020-12-31 $4,913
2020-09-30 $4,732
2020-06-30 $4,718
2020-03-31 $4,886
2019-12-31 $6,248
2019-09-30 $3,735
2019-06-30 $3,705
2019-03-31 $3,941
2018-12-31 $3,836
2018-09-30 $4,162
2018-06-30 $4,074
2018-03-31 $3,990
2017-12-31 $4,268
2017-09-30 $4,728
2017-06-30 $4,465
2017-03-31 $4,247
2016-12-31 $3,609
2016-09-30 $3,897
2016-06-30 $4,226
2016-03-31 $4,597
2015-12-31 $5,313
2015-09-30 $4,651
2015-06-30 $4,291
2015-03-31 $3,097
2014-12-31 $2,708
2014-09-30 $3,143
2014-06-30 $2,496
2014-03-31 $2,563
2013-12-31 $2,513
2013-09-30 $2,853
2013-06-30 $1,762
2013-03-31 $1,646
2012-12-31 $1,823
2012-09-30 $1,159
2012-06-30 $1,049
2012-03-31 $958
2011-12-31 $924
2011-09-30 $863
2011-06-30 $762
2011-03-31 $661
2010-12-31 $692
2010-09-30 $846
2010-06-30 $234
2010-03-31 $208
2009-12-31 $249
2009-09-30 $219
2009-06-30 $217
2009-03-31 $230
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00